IceCure Medical (NASDAQ:ICCM – Get Rating) released its quarterly earnings data on Monday. The company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.01, MarketWatch Earnings reports. The business had revenue of $0.71 million during the quarter, compared to analyst estimates of $0.95 million. IceCure Medical had a […]
IceCure Medical (NASDAQ:ICCM – Get Rating) is set to announce its earnings results before the market opens on Monday, May 22nd. Analysts expect the company to announce earnings of ($0.09) per share for the quarter. IceCure Medical (NASDAQ:ICCM – Get Rating) last issued its earnings results on Wednesday, March 29th. The company reported ($0.11) earnings […]
IceCure Medical (NASDAQ:ICCM – Get Rating) and Penumbra (NYSE:PEN – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership. Volatility & Risk IceCure Medical has a beta of -0.25, meaning […]
IceCure Medical (NASDAQ:ICCM – Get Rating) posted its earnings results on Wednesday. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.09) by ($0.02), reports. IceCure Medical had a negative return on equity of 89.17% and a negative net margin of 550.34%. The company had revenue of $0.94 million […]
HC Wainwright reaffirmed their buy rating on shares of IceCure Medical (NASDAQ:ICCM – Get Rating) in a research report sent to investors on Tuesday, Benzinga reports. HC Wainwright currently has a $3.00 target price on the stock. IceCure Medical Price Performance Shares of NASDAQ ICCM opened at $1.17 on Tuesday. IceCure Medical has a 1-year […]